<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/320A95D7-E544-4371-ACAC-D706B4093FD6"><gtr:id>320A95D7-E544-4371-ACAC-D706B4093FD6</gtr:id><gtr:firstName>David Anthony</gtr:firstName><gtr:surname>Price</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/937E637A-EF12-44AC-96D6-B8C237A7C9D5"><gtr:id>937E637A-EF12-44AC-96D6-B8C237A7C9D5</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>Kelvin</gtr:otherNames><gtr:surname>Sewell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3DA6FD76-F435-4DE8-AEEF-443A6675F3C6"><gtr:id>3DA6FD76-F435-4DE8-AEEF-443A6675F3C6</gtr:id><gtr:firstName>Linda</gtr:firstName><gtr:surname>Wooldridge</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FH001085%2F1"><gtr:id>8AB43E4F-9CC0-404B-B2D3-5313B1958501</gtr:id><gtr:title>Comprehensive analysis of T-cell receptor degeneracy and T-cell crossreactivity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/H001085/1</gtr:grantReference><gtr:abstractText>T-cells are white blood cells designed to protect our bodies from infection. The devastating effects of low numbers of just one type of T-cell are all too evident in HIV-AIDS. T-cells perform extremely important roles because: (1) They orchestrate immunity and are key elements in the control of infection; (2) They are important for the natural eradication of cancer; (3) They hold the key to successful vaccination; (4) They mediate many allergic reactions; (5) They play a substantial role in transplant rejection; and, (6) When they go wrong, they are the cells that cause autoimmune diseases such as diabetes, arthritis and multiple sclerosis. Our T-cells spring into action when the molecules on their surface called T-cell receptors (TCRs) recognize bits of microbes and cancer molecules called antigens. It is estimated that we have T-cells with about 25 million different TCRs in our bodies. TCRs are extremely important molecules because they are at the very focal point of all the above roles. In addition, TCRs are largely responsible for how our immune systems 'learn' and therefore protect us from subsequent exposures to the same germs. In order to deal with all possible infections, our T-cells have to be able to recognize more than 1,000,000,000,000,000 different 'foreign' antigens that we could encounter. It is clear that the immune system has to cover many more foreign antigens than it has different T-cells. To achieve this, each individual TCR molecule may recognize more than a million different possible antigens. As a result, T-cells are said to be extremely 'crossreactive'. This essential T-cell crossreactivity is permissible because the TCR molecule on the T-cell surface can be tremendously promiscuous and recognize many similar 'shapes'. While TCR promiscuity allows our T-cells to control infection, it is also thought to be responsible for the harmful effects these cells can sometimes cause. Autoimmunity is believed to arise when a TCR that is raised to fight infection is inadvertently promiscuous enough to recognize our own tissue. This promiscuous TCR recognition can also result in allergic reactions and is responsible for why our immune cells attack a 'foreign' organ in the first week after it is transplanted. Thus, TCR promiscuity sits at the very heart of most human disease. Despite its obvious importance, there has never yet been a proper attempt to examine or assess TCR promiscuity and the T-cell crossreactivity it enables. Study of TCR promiscuity will require a longer-term effort by an experienced and interdisciplinary team. In this application, a biochemist (Professor Andy Sewell) an infectious diseases clinician and cellular immunologist (Professor David Price), a veterinarian (Dr. Linda Wooldridge), a structure biologist (Dr. Pierre Rizkallah) and a mathematician (Dr. Hugo van den Berg) will apply their collective expertise in T-cell research to undertake a comprehensive analysis of TCR promiscuity for the first time. New tools that this team has developed have finally provided the keys to unlock this study and make this application especially timely. The potential applications and benefits of this work are immense. We have already built TCRs that are promiscuous enough to see all known immune escape variants of the HIV virus. We have further built TCRs that have better 'shapes' for detecting and eliminating cancer. In addition, we expect that this work will revolutionize vaccination and provide insights into the blight of autoimmune disease. In short, this work represents one of those rare examples of basic biological research that has obvious and numerous potentials for translation to clinical practice. As such, we anticipate that this work will generate valuable spin-offs that will improve clinical practice in addition to furthering our understanding of the very interaction that orchestrates human immunity.</gtr:abstractText><gtr:technicalSummary>The 25 million T-cell receptors (TCRs) in the human na&amp;iuml;ve T-cell pool enable T-cell responses to almost any 'foreign' peptide bound to a 'self' MHC molecule. This complete immune coverage of the array of possible permutations generated from 20 amino acid residues that could bind to the self repertoire of MHC molecules theoretically requires that each TCR must crossreact with over a million different peptides. However, such levels of TCR binding degeneracy encompass the potential for inadvertent recognition of 'self' peptide by TCRs raised against a pathogen; indeed, this is thought to be the root cause of all autoimmunity. Promiscuous TCR recognition can also result in allergic reactions and acute transplant rejection. Despite its obvious importance, there has never been a real attempt to assess TCR degeneracy and T-cell crossreactivity. This paucity of knowledge reflects a lack of methodological tools. Our new technologies and interdisciplinary team now enable the timely fulfilment of this critical research gap. We will use an approach that incorporates T-cell culture/assay, soluble TCR and pMHC manufacture, biophysical/structural analysis of TCR/pMHC interactions, polychromatic flow cytometric dissection of antigen-specific T-cell populations, high throughput direct ex vivo quantitative TCR clonotyping, positional scanning peptide library analysis and bioinformatics to measure TCR degeneracy for the first time. This basic biological research will further our understanding of the very interaction that orchestrates human immunity and will transform the way biologists view T-cell immunity. The study of these pivotal interactions in health will almost certainly be beneficial to understanding their role in disease. This work has obvious and numerous potentials for translation to clinical practice. Our results could influence TCR-based therapies, revolutionize vaccination and illuminate our understanding of autoimmunity.</gtr:technicalSummary><gtr:fund><gtr:end>2015-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2010-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2932789</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have proved that individual T-cells can recognise millions of different peptides. This work has received a Highly Cited award from Thompson Reuters. We believe that this T-cell cross reactivity is the root cause of all autoimmune disease. Our unpublished work points to which pathogen causes type 1 diabetes. 

We have further demonstrated that T-cells can recognise biostable synthetic molecules and that one such molecule can protect humanised mice against lethal challenge with influenza. To the best of our knowledge this is the worlds first truly synthetic vaccine. The non-biologic nature of this compound means that, unlike most conventional vaccines it can be given orally (i.e. it is not digested)</gtr:description><gtr:exploitationPathways>In the long run we believe that studies of this nature will be useful to understanding autoimmune disease and for predicting such diseases before the onset of symptoms.

We also hope to use our approach to build synthetic edible vaccines that can be added to livestock feed.</gtr:exploitationPathways><gtr:id>03568769-A489-4A2A-B7AD-945BF7E8ADB2</gtr:id><gtr:outcomeId>56d067f9570b15.58177368</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Method published:

Bulek, A.M. F. Madura, A. Fuller, C.J. Holland, A.J.A. Schauenburg, A.K. Sewell. P.J. Rizkallah and D.K. Cole (2012). TCR/pMHC optimized protein crystallisation screen. Journal of Immunological Methods, 382, 203-210.</gtr:description><gtr:id>8FBD0853-79ED-4D0C-99E4-E479A9AF73BD</gtr:id><gtr:impact>We have used this method to double the database of TCR/pMHC structures.</gtr:impact><gtr:outcomeId>5460bbf8e93024.40891652</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>TCR/pMHC optimized protein crystallisation screen</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Method published in: 

Wooldridge, L., J. Ekeruche-Makinde, H.A. van den Berg, A. Skowera, J.J. Miles, M.P. Tan, G. Dolton, M. Clement, S. Llewellyn-Lacey, D.A. Price, M. Peakman and A.K. Sewell (2012) A single autoimmune T-cell receptor recognises over a million different peptides. Journal of Biological Chemistry, 287, 1168-77. This paper has been highly cited and was featured in Nature Immunology (volume 13 p197-8)</gtr:description><gtr:id>9E3D89C2-90D3-4899-93B4-821EB446BF4C</gtr:id><gtr:impact>Above paper cited &amp;gt;60 times already. Methodology now used for screening TCRs prior to TCR gene transfer therapy with enhanced TCRs to ensure that there self-reactivity</gtr:impact><gtr:outcomeId>5460bcdc7421e4.19496252</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Method for finding cross-reactive peptides for a T-cell receptor</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B0B62E67-8695-43DF-8D7E-F5ADFD293AA5</gtr:id><gtr:title>CD3?-based chimeric antigen receptors mediate T cell activation via cis- and trans-signalling mechanisms: implications for optimization of receptor structure for adoptive cell therapy.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/608e9c0e34392a2481e8e9fcee956b26"><gtr:id>608e9c0e34392a2481e8e9fcee956b26</gtr:id><gtr:otherNames>Bridgeman JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>doi_55f94b94bea47677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF48AD64-CC32-424E-9FE7-B2C2832819FA</gtr:id><gtr:title>More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0893e8ddad39e952b8d68025a1cfcf13"><gtr:id>0893e8ddad39e952b8d68025a1cfcf13</gtr:id><gtr:otherNames>Dolton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>561651de24bf73.37108527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFCB8B48-1426-4D3D-81AC-46485947DA0D</gtr:id><gtr:title>Design, synthesis and evaluation of ?-lactam antigenic peptide hybrids; unusual opening of the ?-lactam ring in acidic media.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7948043dd13fdc5e90fd98c6ec279ce7"><gtr:id>7948043dd13fdc5e90fd98c6ec279ce7</gtr:id><gtr:otherNames>Tarbe M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>545212334f9e18.32231951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>299E760D-2858-4939-96B7-21463128FEAA</gtr:id><gtr:title>Cellular-level versus receptor-level response threshold hierarchies in T-cell activation.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19d9a7c6cf3ca45d8002b8e2b30d86cc"><gtr:id>19d9a7c6cf3ca45d8002b8e2b30d86cc</gtr:id><gtr:otherNames>van den Berg HA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5452123817f891.09354440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>504835CA-0063-49DC-A444-8EFBC48430A6</gtr:id><gtr:title>A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5f8fb066fe191e4133908ec3df61667"><gtr:id>c5f8fb066fe191e4133908ec3df61667</gtr:id><gtr:otherNames>Gras S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>545212369273d9.18824325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A28C917-5462-4DF4-989A-AA0B0BD5649F</gtr:id><gtr:title>A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8207e4442e399d184afeb051392d8093"><gtr:id>8207e4442e399d184afeb051392d8093</gtr:id><gtr:otherNames>Ladell K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>doi_55fa9ea9e2b00cca</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80C303E4-7339-4185-8075-3DB2AD47CA5E</gtr:id><gtr:title>Modification of MHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e63e74c220ec196eca0bf3c62165deb"><gtr:id>1e63e74c220ec196eca0bf3c62165deb</gtr:id><gtr:otherNames>Cole DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>54521233060894.96704205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E91C01C-A5A1-4089-9E05-1BFDF72B1648</gtr:id><gtr:title>Structural basis for ineffective T-cell responses to MHC anchor residue-improved &amp;quot;heteroclitic&amp;quot; peptides.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fefac5bc80075ba4ab5d1dd679349f6"><gtr:id>2fefac5bc80075ba4ab5d1dd679349f6</gtr:id><gtr:otherNames>Madura F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>56164f88e70668.11186368</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60FAE046-0D0E-4E0C-B8FC-DD956920FDFC</gtr:id><gtr:title>A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37c9cf8875b98ee73f2938bc9a9449f8"><gtr:id>37c9cf8875b98ee73f2938bc9a9449f8</gtr:id><gtr:otherNames>Bianchi V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5809f562ad9b09.10778822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A965524-9359-46A7-8D75-E144E1B934D6</gtr:id><gtr:title>T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR-major histocompatibility complex interactions.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e63e74c220ec196eca0bf3c62165deb"><gtr:id>1e63e74c220ec196eca0bf3c62165deb</gtr:id><gtr:otherNames>Cole DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>545212383fcca6.44431527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D27535C-2621-496B-8B78-93E5DD53ACDB</gtr:id><gtr:title>Modification of the carboxy-terminal flanking region of a universal influenza epitope alters CD4? T-cell repertoire selection.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e63e74c220ec196eca0bf3c62165deb"><gtr:id>1e63e74c220ec196eca0bf3c62165deb</gtr:id><gtr:otherNames>Cole DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>54521234d8f934.53085342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57232416-61C4-42DE-AD7E-89269120CB0C</gtr:id><gtr:title>Coreceptor scanning by the T cell receptor provides a mechanism for T cell tolerance.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcadc8979fda18e278ae17c97cbe2ede"><gtr:id>dcadc8979fda18e278ae17c97cbe2ede</gtr:id><gtr:otherNames>Stepanek O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>5452123938bc03.76768089</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0E91964-946E-49C0-B02A-0C8C783DAC70</gtr:id><gtr:title>T-cell receptor specificity maintained by altered thermodynamics.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fefac5bc80075ba4ab5d1dd679349f6"><gtr:id>2fefac5bc80075ba4ab5d1dd679349f6</gtr:id><gtr:otherNames>Madura F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>545212375e7649.64574898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>622F3A11-0415-4091-9209-8B7AAEF08BD3</gtr:id><gtr:title>Peptide length determines the outcome of TCR/peptide-MHCI engagement.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/992b542acd15f78e277d8de28fa4f4e7"><gtr:id>992b542acd15f78e277d8de28fa4f4e7</gtr:id><gtr:otherNames>Ekeruche-Makinde J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>54521236e00593.50997946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B3E1B76-0C9B-4EC0-9750-8AC390AA9C7D</gtr:id><gtr:title>Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab8356ea967ef3a5292d593d6743d531"><gtr:id>ab8356ea967ef3a5292d593d6743d531</gtr:id><gtr:otherNames>Motozono C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>561651de5ca468.01230227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D065F9AE-4FB5-4409-89AD-D9C4253D9882</gtr:id><gtr:title>Identification of human viral protein-derived ligands recognized by individual MHCI-restricted T-cell receptors.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e54f9c9e464fb4226e4ed87355682bc9"><gtr:id>e54f9c9e464fb4226e4ed87355682bc9</gtr:id><gtr:otherNames>Szomolay B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>56d0698a2e9460.08938860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8E37BBA-B5C8-4BAC-A59D-654B42B93573</gtr:id><gtr:title>Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B*51:01.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab8356ea967ef3a5292d593d6743d531"><gtr:id>ab8356ea967ef3a5292d593d6743d531</gtr:id><gtr:otherNames>Motozono C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>545212388e3072.38057898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FE47881-F886-4E7F-B9FC-390B84223B32</gtr:id><gtr:title>CD8(+) T cell cross-reactivity profiles and HIV-1 immune escape towards an HLA-B35-restricted immunodominant Nef epitope.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab8356ea967ef3a5292d593d6743d531"><gtr:id>ab8356ea967ef3a5292d593d6743d531</gtr:id><gtr:otherNames>Motozono C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54521237bdcbb2.89688745</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6D04389-912F-4A13-907E-A490F65A3BEF</gtr:id><gtr:title>Co-Receptor CD8-Mediated Modulation of T-Cell Receptor Functional Sensitivity and Epitope Recognition Degeneracy.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e54f9c9e464fb4226e4ed87355682bc9"><gtr:id>e54f9c9e464fb4226e4ed87355682bc9</gtr:id><gtr:otherNames>Szomolay B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a3513036823e3.29227723</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25451C1D-0287-4E7E-BC75-3E9EF7D04A72</gtr:id><gtr:title>T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/992b542acd15f78e277d8de28fa4f4e7"><gtr:id>992b542acd15f78e277d8de28fa4f4e7</gtr:id><gtr:otherNames>Ekeruche-Makinde J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>545212360a5876.09836525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C49DB11-81DD-4C9B-83CF-3647232A8ED5</gtr:id><gtr:title>Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fb25d83715c29e0eaf7b3a566c436ba"><gtr:id>0fb25d83715c29e0eaf7b3a566c436ba</gtr:id><gtr:otherNames>Matthews PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5452123669a0c1.24328843</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA0F0D32-040B-451C-8987-C540B5251AA9</gtr:id><gtr:title>Comparison of peptide-major histocompatibility complex tetramers and dextramers for the identification of antigen-specific T cells.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0893e8ddad39e952b8d68025a1cfcf13"><gtr:id>0893e8ddad39e952b8d68025a1cfcf13</gtr:id><gtr:otherNames>Dolton G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>54521238b21f72.95751678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F56BEB79-E14B-4664-8657-558A2D2FB6DF</gtr:id><gtr:title>A single autoimmune T cell receptor recognizes more than a million different peptides.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d547e90cc384e09a297316e7446f9b8"><gtr:id>6d547e90cc384e09a297316e7446f9b8</gtr:id><gtr:otherNames>Wooldridge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5452123476f926.58708912</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B450A46-4749-428A-9FFB-0094585DDA8F</gtr:id><gtr:title>Clonotypically similar hybrid a? T cell receptors can exhibit markedly different surface expression, antigen specificity and cross-reactivity.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab8356ea967ef3a5292d593d6743d531"><gtr:id>ab8356ea967ef3a5292d593d6743d531</gtr:id><gtr:otherNames>Motozono C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>561651dccfc387.52389046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBFDCDA2-1895-4592-9762-483A5237D6C3</gtr:id><gtr:title>Structural Mechanism Underpinning Cross-reactivity of a CD8+ T-cell Clone That Recognizes a Peptide Derived from Human Telomerase Reverse Transcriptase.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e63e74c220ec196eca0bf3c62165deb"><gtr:id>1e63e74c220ec196eca0bf3c62165deb</gtr:id><gtr:otherNames>Cole DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>58921a3ee18a99.33419861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8418053-5815-47DC-89A3-1B3102B47899</gtr:id><gtr:title>Monoclonal TCR-redirected tumor cell killing.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84fb55c2619a356e32c237ee4c7930d6"><gtr:id>84fb55c2619a356e32c237ee4c7930d6</gtr:id><gtr:otherNames>Liddy N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>545212350e1fc4.55882941</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0B15042-F92E-4551-BED9-F0582E512E53</gtr:id><gtr:title>Real time detection of peptide-MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stability.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b07196ba718758d96120fa220b02f38a"><gtr:id>b07196ba718758d96120fa220b02f38a</gtr:id><gtr:otherNames>Miles KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>545212339e6f42.97562224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FB363FD-D229-4B09-8932-C4CE22FB1039</gtr:id><gtr:title>Thermal Stability of Heterotrimeric pMHC Proteins as Determined by Circular Dichroism Spectroscopy.</gtr:title><gtr:parentPublicationTitle>Bio-protocol</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0cb61436c206f0dd93870d26e445e453"><gtr:id>0cb61436c206f0dd93870d26e445e453</gtr:id><gtr:otherNames>Fuller A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2331-8325</gtr:issn><gtr:outcomeId>5a318cfa314a79.34386400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E14A0B44-3D2C-4551-BF40-924AB064F644</gtr:id><gtr:title>Why must T cells be cross-reactive?</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/372373b81c8c2308306cfaabf73680f9"><gtr:id>372373b81c8c2308306cfaabf73680f9</gtr:id><gtr:otherNames>Sewell AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>54521235895332.67273434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>714233CD-9D2C-4A13-B774-C088D2C60640</gtr:id><gtr:title>Minimal conformational plasticity enables TCR cross-reactivity to different MHC class II heterodimers.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6336644e31f463c287f39878682c1aec"><gtr:id>6336644e31f463c287f39878682c1aec</gtr:id><gtr:otherNames>Holland CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>545212362f8cb4.01855924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47E48250-7CEE-4A40-93B6-6FC1E93E38CD</gtr:id><gtr:title>Naive CD8&amp;acirc;?&amp;ordm; T-cell precursors display structured TCR repertoires and composite antigen-driven selection dynamics.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/263ecc7a9136a16b51543c88e952d585"><gtr:id>263ecc7a9136a16b51543c88e952d585</gtr:id><gtr:otherNames>Neller MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>585d762e4c21e9.61451202</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDC6BC6F-80A8-4581-88F7-3AD22E0DA5AD</gtr:id><gtr:title>Modulation of T-cell receptor functional sensitivity via the opposing actions of protein tyrosine kinases and phosphatases: a mathematical model.</gtr:title><gtr:parentPublicationTitle>Integrative biology : quantitative biosciences from nano to macro</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e54f9c9e464fb4226e4ed87355682bc9"><gtr:id>e54f9c9e464fb4226e4ed87355682bc9</gtr:id><gtr:otherNames>Szomolay B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1757-9694</gtr:issn><gtr:outcomeId>5675dc3acbfa9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>857B1FA2-FEFE-4D2C-97A6-BA713B0654A5</gtr:id><gtr:title>CD8 controls T cell cross-reactivity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d547e90cc384e09a297316e7446f9b8"><gtr:id>6d547e90cc384e09a297316e7446f9b8</gtr:id><gtr:otherNames>Wooldridge L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5452123329be61.56798985</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84D581AE-74AC-44CA-8D41-E52413B7F0F6</gtr:id><gtr:title>Dual Molecular Mechanisms Govern Escape at Immunodominant HLA A2-Restricted HIV Epitope.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e63e74c220ec196eca0bf3c62165deb"><gtr:id>1e63e74c220ec196eca0bf3c62165deb</gtr:id><gtr:otherNames>Cole DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a9a6a7c803fd9.52387822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E408182-95DB-4A7D-984F-18A383652A20</gtr:id><gtr:title>Structural and biophysical determinants of a? T-cell antigen recognition.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/608e9c0e34392a2481e8e9fcee956b26"><gtr:id>608e9c0e34392a2481e8e9fcee956b26</gtr:id><gtr:otherNames>Bridgeman JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>545212344bb594.22318766</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D9993E0-CE82-4F15-AE7F-CB86989206B9</gtr:id><gtr:title>&amp;Icirc;&amp;plusmn;&amp;Icirc;&amp;sup2; T cell receptors as predictors of health and disease.</gtr:title><gtr:parentPublicationTitle>Cellular &amp; molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe1349512d1f6d81f07bc336dee03bfb"><gtr:id>fe1349512d1f6d81f07bc336dee03bfb</gtr:id><gtr:otherNames>Attaf M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1672-7681</gtr:issn><gtr:outcomeId>561651dca2fa68.02356104</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAA731FF-EDE1-4AFE-B963-DAC2582552C8</gtr:id><gtr:title>TCR/pMHC Optimized Protein crystallization Screen.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56dc92676fb2486aed9c0f0f153df562"><gtr:id>56dc92676fb2486aed9c0f0f153df562</gtr:id><gtr:otherNames>Bulek AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>54521235368260.02559510</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59DE2908-6BFC-4069-8FBF-F366E4787534</gtr:id><gtr:title>Advances in T-cell epitope engineering.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0346f30d9d083c4a6475e2cc7557f98e"><gtr:id>0346f30d9d083c4a6475e2cc7557f98e</gtr:id><gtr:otherNames>Pentier JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>54521237833958.30791842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>604CFB5D-FF7A-466C-833E-0FB5CC0FE29B</gtr:id><gtr:title>Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1cd528ca89a12d59e44186f2e5891f"><gtr:id>3c1cd528ca89a12d59e44186f2e5891f</gtr:id><gtr:otherNames>Laugel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>58921b9007a8c1.67061930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>199ACD3A-4989-41A0-B422-8577B885EA4F</gtr:id><gtr:title>Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56dc92676fb2486aed9c0f0f153df562"><gtr:id>56dc92676fb2486aed9c0f0f153df562</gtr:id><gtr:otherNames>Bulek AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>545212349d66e9.78113215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14D9F881-9B88-45DF-8B16-553A79E8F3A2</gtr:id><gtr:title>Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e63e74c220ec196eca0bf3c62165deb"><gtr:id>1e63e74c220ec196eca0bf3c62165deb</gtr:id><gtr:otherNames>Cole DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>5809f562d28082.46766650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3F972EE-9CAD-4635-803E-4BB422CFC5E5</gtr:id><gtr:title>The multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self-reactive cytotoxic T cells.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c1cd528ca89a12d59e44186f2e5891f"><gtr:id>3c1cd528ca89a12d59e44186f2e5891f</gtr:id><gtr:otherNames>Laugel B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>54521233ef0419.78612031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D821438-32D6-40FD-A708-A41D2B1D31FE</gtr:id><gtr:title>Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/312af8f4a0e08b0d2cd5cfe5db91775d"><gtr:id>312af8f4a0e08b0d2cd5cfe5db91775d</gtr:id><gtr:otherNames>Miles JJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>545212337762c0.63250759</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DDE3EB1-F8E0-498F-90BD-96C55D4A9A8B</gtr:id><gtr:title>The versatility of the a? T-cell antigen receptor.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae7c03f706b0ca9d1b427c6c9f6ddaef"><gtr:id>ae7c03f706b0ca9d1b427c6c9f6ddaef</gtr:id><gtr:otherNames>Bhati M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>54521238642465.09539770</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/H001085/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>